Scott Henry
Stock Analyst at Alliance Global Partners
(1.28)
# 3,693
Out of 5,157 analysts
60
Total ratings
38.46%
Success rate
-5.11%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.79 | +278.84% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.04 | +260.58% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.35 | +346.10% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $8.11 | +23.30% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $11.63 | +254.69% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.15 | +4.29% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.82 | +387.80% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.36 | +346.43% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $240 | $2.61 | +9,095.40% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $5.79 | +29.48% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.37 | +38.74% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $34.66 | -30.76% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $212.29 | -57.61% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.77 | -37.42% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $109.20 | -46.89% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $98.95 | -63.62% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.34 | +720.90% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.25 | +41.18% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $0.82 | +701,119.51% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.13 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.68 | +937.04% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $14.17 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.26 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.79
Upside: +278.84%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.04
Upside: +260.58%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.35
Upside: +346.10%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $8.11
Upside: +23.30%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $11.63
Upside: +254.69%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.15
Upside: +4.29%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.82
Upside: +387.80%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.36
Upside: +346.43%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $240
Current: $2.61
Upside: +9,095.40%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $5.79
Upside: +29.48%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.37
Upside: +38.74%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $34.66
Upside: -30.76%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $212.29
Upside: -57.61%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.77
Upside: -37.42%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $109.20
Upside: -46.89%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $98.95
Upside: -63.62%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.34
Upside: +720.90%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.25
Upside: +41.18%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $0.82
Upside: +701,119.51%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.68
Upside: +937.04%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $14.17
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.26
Upside: -